Lovastatin Tablet
Product Images NDC 51655-873

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 51655-873). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 873 52 Rev A 04 23)

Label for Lovastatin Tablets, USP 10 mg, containing 30 tablets. The prescription drug is labeled for oral use and distributed by Northwind Pharmaceuticals in Indianapolis, IN. Storage instructions and barcode are visible alongside NDC 51655-873-52 and packaging details.*

FDA Label Image

Lovastatin (65abb8c3 847f 4fb3 B8de 21888c01210b 01)

Chemical structure of lovastatin, depicting its molecular arrangement with various functional groups including hydroxyl (OH), keto (C=O), and several methyl (CH3) groups.*

FDA Label Image

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' comparing the proportion of participants without event over years of follow-up between Lovastatin and Placebo groups. The graph shows a greater proportion of event-free participants in the Lovastatin group, with a noted 37% risk reduction (p<0.0001) compared to placebo over approximately six years.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.